- Patent Title: Treatement of pathogen infections formulations and methods for use
-
Application No.: US17184177Application Date: 2021-02-24
-
Publication No.: US11583574B2Publication Date: 2023-02-21
- Inventor: Mitchell Lynn Tate
- Applicant: Mitchell Lynn Tate
- Applicant Address: US AZ Surprise
- Assignee: Mitchell Lynn Tate
- Current Assignee: Mitchell Lynn Tate
- Current Assignee Address: US AZ Surprise
- Agency: Pate Baird, PLLC
- Main IPC: A61K38/44
- IPC: A61K38/44 ; A61K36/19 ; A61K36/752 ; A61K9/08 ; A61K9/00 ; A61K47/46 ; A61K47/02 ; A61P31/14
Abstract:
An oral product comprising nano-sized, heat tolerable, shelf stable peptides and enzymes. Once the peptides and enzymes are inside the body of a user, they dimerize the nucleic acids of viruses, bacteria and fungi. Thus, the peptides and enzymes are capable of inactivating the genome of pathogens, including without limitation, SARS-CoV-2 and Influenza A/CA/04/2009 (H1N1) virus.
Public/Granted literature
- US20210308232A1 TREATEMENT OF PATHOGEN INFECTIONS FORMULATIONS AND METHODS FOR USE Public/Granted day:2021-10-07
Information query
IPC分类:
